GBST Announces Unaudited Earnings Results for the Year Ended 30 June 2017; Provides Earnings Guidance for the Year 2018
For the year 2018, the company expects operating EBITDA before strategic R&D in product development in the range of $20 million - $25 million. Strategic R&D in product development expenditure is expected to be in the range of $10 million - $15 million, with $10 million - $12 million of that related to E-VOLVE and Composer Web 2.0.